{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:59:14Z","timestamp":1791187154029,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,3,29]],"date-time":"2006-03-29T00:00:00Z","timestamp":1143590400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1007\/s00125-006-0206-7","type":"journal-article","created":{"date-parts":[[2006,3,28]],"date-time":"2006-03-28T08:14:17Z","timestamp":1143533657000},"page":"1237-1246","source":"Crossref","is-referenced-by-count":108,"title":["Intracellular amyloid-like deposits contain unprocessed pro-islet amyloid polypeptide (proIAPP) in beta cells of transgenic mice overexpressing the gene for human IAPP and transplanted human islets"],"prefix":"10.1007","volume":"49","author":[{"given":"J. F.","family":"Paulsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Westermark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. T.","family":"Westermark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,3,29]]},"reference":[{"key":"206_CR1","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/BF00274799","volume":"30","author":"P Westermark","year":"1987","unstructured":"Westermark P, Wilander E, Westermark GT, Johnson KH (1987) Islet amyloid polypeptide-like immunoreactivity in the islet B cells of type 2 (non-insulin-dependent) diabetic and non-diabetic individuals. Diabetologia 30:887\u2013892","journal-title":"Diabetologia"},{"key":"206_CR2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0006-291X(86)90708-4","volume":"140","author":"P Westermark","year":"1986","unstructured":"Westermark P, Wernstedt C, Wilander E, Sletten K (1986) A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 140:827\u2013831","journal-title":"Biochem Biophys Res Commun"},{"key":"206_CR3","doi-asserted-by":"crossref","first-page":"17243","DOI":"10.1016\/S0021-9258(19)77825-9","volume":"263","author":"T Sanke","year":"1988","unstructured":"Sanke T, Bell GI, Sample C, Rubenstein AH, Steiner DF (1988) An islet amyloid peptide is derived from an 89-amino acid precursor by proteolytic processing. J Biol Chem 263:17243\u201317246","journal-title":"J Biol Chem"},{"key":"206_CR4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0014-5793(95)01460-8","volume":"378","author":"MK Badman","year":"1996","unstructured":"Badman MK, Shennan KI, Jermany JL, Docherty K, Clark A (1996) Processing of pro-islet amyloid polypeptide (proIAPP) by the prohormone convertase PC2. FEBS Lett 378:227\u2013231","journal-title":"FEBS Lett"},{"key":"206_CR5","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1046\/j.1432-1327.2000.01548.x","volume":"267","author":"CE Higham","year":"2000","unstructured":"Higham CE, Hull RL, Lawrie L et al (2000) Processing of synthetic pro-islet amyloid polypeptide (proIAPP) \u2018amylin\u2019 by recombinant prohormone convertase enzymes, PC2 and PC3, in vitro. Eur J Biochem 267:4998\u20135004","journal-title":"Eur J Biochem"},{"key":"206_CR6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diabetes.53.1.141","volume":"53","author":"L Marzban","year":"2004","unstructured":"Marzban L, Trigo-Gonzalez G, Zhu X et al (2004) Role of beta-cell prohormone convertase (PC)1\/3 in processing of pro-islet amyloid polypeptide. Diabetes 53:141\u2013148","journal-title":"Diabetes"},{"key":"206_CR7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-5793(83)81065-5","volume":"162","author":"K Docherty","year":"1983","unstructured":"Docherty K, Hutton JC (1983) Carboxypeptidase activity in the insulin secretory granule. FEBS Lett 162:137\u2013141","journal-title":"FEBS Lett"},{"key":"206_CR8","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1210\/en.2004-1175","volume":"146","author":"L Marzban","year":"2005","unstructured":"Marzban L, Soukhatcheva G, Verchere C (2005) Role of carboxypeptidase E in processing of pro-islet amyloid polypeptide in beta-cells. Endocrinology 146:1808\u20131817","journal-title":"Endocrinology"},{"key":"206_CR9","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1242\/jcs.110.6.695","volume":"110","author":"S Milgram","year":"1997","unstructured":"Milgram S, Kho S, Martin G, Mains R, Eipper B (1997) Localization of integral membrane peptidylglycine alpha-amidating monooxygenase in neuroendocrine cells. J Cell Sci 110:695\u2013706","journal-title":"J Cell Sci"},{"key":"206_CR10","doi-asserted-by":"crossref","first-page":"9662","DOI":"10.1073\/pnas.86.24.9662","volume":"86","author":"AN Roberts","year":"1989","unstructured":"Roberts AN, Leighton B, Todd JA et al (1989) Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus. Proc Natl Acad Sci USA 86:9662\u20139666","journal-title":"Proc Natl Acad Sci USA"},{"key":"206_CR11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF00285291","volume":"32","author":"A Lukinius","year":"1989","unstructured":"Lukinius A, Wilander E, Westermark GT, Engstrom U, Westermark P (1989) Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets. Diabetologia 32:240\u2013244","journal-title":"Diabetologia"},{"key":"206_CR12","doi-asserted-by":"crossref","first-page":"8822","DOI":"10.1073\/pnas.89.18.8822","volume":"89","author":"SP Smeekens","year":"1992","unstructured":"Smeekens SP, Montag AG, Thomas G et al (1992) Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3. Proc Natl Acad Sci USA 89:8822\u20138826","journal-title":"Proc Natl Acad Sci USA"},{"key":"206_CR13","first-page":"811","volume":"78","author":"MB Block","year":"1971","unstructured":"Block MB, Mako M, Steiner DF, Rubenstein AH (1971) Elevated circulating proinsulin levels in insulin-requiring diabetic patients. J Lab Clin Med 78:811\u2013812","journal-title":"J Lab Clin Med"},{"key":"206_CR14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2337\/diab.44.2.173","volume":"44","author":"SE Kahn","year":"1995","unstructured":"Kahn SE, Leonetti DL, Prigeon RL, Boyko EJ, Bergstrom RW, Fujimoto WY (1995) Proinsulin as a marker for the development of NIDDM in Japanese\u2013American men. Diabetes 44:173\u2013179","journal-title":"Diabetes"},{"key":"206_CR15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1172\/JCI118435","volume":"97","author":"ER Seaquist","year":"1996","unstructured":"Seaquist ER, Kahn SE, Clark PM, Hales CN, Porte D Jr, Robertson RP (1996) Hyperproinsulinemia is associated with increased beta cell demand after hemipancreatectomy in humans. J Clin Invest 97:455\u2013460","journal-title":"J Clin Invest"},{"key":"206_CR16","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2337\/diab.46.11.1725","volume":"46","author":"SE Kahn","year":"1997","unstructured":"Kahn SE, Halban PA (1997) Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM. Diabetes 46:1725\u20131732","journal-title":"Diabetes"},{"key":"206_CR17","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2337\/diabetes.48.7.1395","volume":"48","author":"H Furukawa","year":"1999","unstructured":"Furukawa H, Carroll RJ, Swift HH, Steiner DF (1999) Long-term elevation of free fatty acids leads to delayed processing of proinsulin and prohormone convertases 2 and 3 in the pancreatic beta-cell line MIN6. Diabetes 48:1395\u20131401","journal-title":"Diabetes"},{"key":"206_CR18","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed R, Head E, Thompson J et al (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486\u2013489","journal-title":"Science"},{"key":"206_CR19","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/368756a0","volume":"368","author":"A Lorenzo","year":"1994","unstructured":"Lorenzo A, Razzaboni B, Weir G, Yankner B (1994) Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368:756\u2013760","journal-title":"Nature"},{"key":"206_CR20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diabetes.48.3.491","volume":"48","author":"J Janson","year":"1999","unstructured":"Janson J, Ashley R, Harrison D, McIntyre S, Butler P (1999) The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 48:491\u2013498","journal-title":"Diabetes"},{"key":"206_CR21","doi-asserted-by":"crossref","first-page":"11338","DOI":"10.1021\/bi020314u","volume":"41","author":"M Anguiano","year":"2002","unstructured":"Anguiano M, Nowak R, Lansbury PJ (2002) Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes. Biochemistry 41:11338\u201311343","journal-title":"Biochemistry"},{"key":"206_CR22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.febslet.2004.09.075","volume":"577","author":"E Sparr","year":"2004","unstructured":"Sparr E, Engel M, Sakharov D et al (2004) Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers. FEBS Lett 577:117\u2013120","journal-title":"FEBS Lett"},{"key":"206_CR23","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2337\/diabetes.54.7.2117","volume":"54","author":"JF Paulsson","year":"2005","unstructured":"Paulsson JF, Westermark GT (2005) Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formation. Diabetes 54:2117\u20132125","journal-title":"Diabetes"},{"key":"206_CR24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2337\/diab.43.2.329","volume":"43","author":"TD O\u2019Brien","year":"1994","unstructured":"O\u2019Brien TD, Butler AE, Roche PC, Johnson KH, Butler PC (1994) Islet amyloid polypeptide in human insulinomas. Evidence for intracellular amyloidogenesis. Diabetes 43:329\u2013336","journal-title":"Diabetes"},{"key":"206_CR25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/2000-1967-113","volume":"108","author":"GT Westermark","year":"2003","unstructured":"Westermark GT, Westermark P, Nordin A, Tornelius E, Andersson A (2003) Formation of amyloid in human pancreatic islets transplanted to the liver and spleen of nude mice. Ups J Med Sci 108:193\u2013203","journal-title":"Ups J Med Sci"},{"key":"206_CR26","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/BF03402051","volume":"6","author":"G Westermark","year":"2000","unstructured":"Westermark G, Gebre-Medhin S, Steiner DF, Westermark P (2000) Islet amyloid development in a mouse strain lacking endogenous islet amyloid polypeptide (IAPP) but expressing human IAPP. Mol Med 6:998\u20131007","journal-title":"Mol Med"},{"key":"206_CR27","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2337\/diab.45.8.1094","volume":"45","author":"M Couce","year":"1996","unstructured":"Couce M, Kane LA, O\u2019Brien TD et al (1996) Treatment with growth hormone and dexamethasone in mice transgenic for human islet amyloid polypeptide causes islet amyloidosis and beta-cell dysfunction. Diabetes 45:1094\u20131101","journal-title":"Diabetes"},{"key":"206_CR28","doi-asserted-by":"crossref","first-page":"7283","DOI":"10.1073\/pnas.93.14.7283","volume":"93","author":"J Janson","year":"1996","unstructured":"Janson J, Soeller W, Roche P et al (1996) Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci USA 93:7283\u20137288","journal-title":"Proc Natl Acad Sci USA"},{"key":"206_CR29","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF00400722","volume":"38","author":"P Westermark","year":"1995","unstructured":"Westermark P, Eizirik DL, Pipeleers DG, Hellerstrom C, Andersson A (1995) Rapid deposition of amyloid in human islets transplanted into nude mice. Diabetologia 38:543\u2013549","journal-title":"Diabetologia"},{"key":"206_CR30","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0026-0495(99)90102-6","volume":"48","author":"G Westermark","year":"1999","unstructured":"Westermark G, Westermark P, Eizirik DL et al (1999) Differences in amyloid deposition in islets of transgenic mice expressing human islet amyloid polypeptide versus human islets implanted into nude mice. Metabolism 48:448\u2013454","journal-title":"Metabolism"},{"key":"206_CR31","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1177\/13.8.693","volume":"13","author":"H Puchtler","year":"1965","unstructured":"Puchtler H, Sweat F (1965) Congo red as a stain for fluorescence microscopy of amyloid. J Histochem Cytochem 13:693\u2013694","journal-title":"J Histochem Cytochem"},{"key":"206_CR32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/13506120209114823","volume":"9","author":"P Westermark","year":"2002","unstructured":"Westermark P, Benson M, Buxbaum J et al (2002) Amyloid fibril protein nomenclature\u20142002. Amyloid 9:197\u2013200","journal-title":"Amyloid"},{"key":"206_CR33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0014-5793(95)01512-4","volume":"379","author":"P Westermark","year":"1996","unstructured":"Westermark P, Li ZC, Westermark GT, Leckstrom A, Steiner DF (1996) Effects of beta cell granule components on human islet amyloid polypeptide fibril formation. FEBS Lett 379:203\u2013206","journal-title":"FEBS Lett"},{"key":"206_CR34","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/BF03402092","volume":"8","author":"Z Ma","year":"2002","unstructured":"Ma Z, Westermark GT (2002) Effects of free fatty acid on polymerization of islet amyloid polypeptide (IAPP) in vitro and on amyloid fibril formation in cultivated isolated islets of transgenic mice overexpressing human IAPP. Mol Med 8:863\u2013868","journal-title":"Mol Med"},{"key":"206_CR35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s001250051295","volume":"42","author":"DL MacArthur","year":"1999","unstructured":"MacArthur DL, de Koning EJ, Verbeek JS, Morris JF, Clark A (1999) Amyloid fibril formation is progressive and correlates with beta-cell secretion in transgenic mouse isolated islets. Diabetologia 42:219\u2013227","journal-title":"Diabetologia"},{"key":"206_CR36","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jmb.2004.06.086","volume":"341","author":"JD Knight","year":"2004","unstructured":"Knight JD, Miranker AD (2004) Phospholipid catalysis of diabetic amyloid assembly. J Mol Biol 341:1175\u20131187","journal-title":"J Mol Biol"},{"key":"206_CR37","doi-asserted-by":"crossref","first-page":"12113","DOI":"10.1021\/bi050840w","volume":"44","author":"SA Jayasinghe","year":"2005","unstructured":"Jayasinghe SA, Langen R (2005) Lipid membranes modulate the structure of islet amyloid polypeptide. Biochemistry 44:12113\u201312119","journal-title":"Biochemistry"},{"key":"206_CR38","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1006\/bbrc.1997.7014","volume":"236","author":"S Janciauskiene","year":"1997","unstructured":"Janciauskiene S, Eriksson S, Carlemalm E, Ahren B (1997) B cell granule peptides affect human islet amyloid polypeptide (IAPP) fibril formation in vitro. Biochem Biophys Res Commun 236:580\u2013585","journal-title":"Biochem Biophys Res Commun"},{"key":"206_CR39","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1042\/bj20030852","volume":"377","author":"E Jaikaran","year":"2004","unstructured":"Jaikaran E, Nilsson M, Clark A (2004) Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation. Biochem J 377:709\u2013716","journal-title":"Biochem J"},{"key":"206_CR40","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1073\/pnas.93.8.3492","volume":"93","author":"CB Verchere","year":"1996","unstructured":"Verchere CB, D\u2019Alessio DA, Palmiter RD et al (1996) Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci USA 93:3492\u20133496","journal-title":"Proc Natl Acad Sci USA"},{"key":"206_CR41","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.2337\/diabetes.54.7.2235","volume":"54","author":"RL Hull","year":"2005","unstructured":"Hull RL, Shen ZP, Watts MR et al (2005) Long-term treatment with rosiglitazone and metformin reduces the extent of, but does not prevent, islet amyloid deposition in mice expressing the gene for human islet amyloid polypeptide. Diabetes 54:2235\u20132244","journal-title":"Diabetes"},{"key":"206_CR42","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature01478","volume":"422","author":"Y Itoh","year":"2003","unstructured":"Itoh Y, Kawamata Y, Harada M et al (2003) Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422:173\u2013176","journal-title":"Nature"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-006-0206-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-006-0206-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-006-0206-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T21:42:01Z","timestamp":1683409321000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-006-0206-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,29]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["206"],"URL":"https:\/\/doi.org\/10.1007\/s00125-006-0206-7","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,29]]}}}